Clinical Trial Update: Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating maintenance cabozantinib with best supportive care versus best supportive care alone in children and adolescents with osteosarcoma ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Ipsen | Conditions: Osteosarcoma, Osteosarcoma in Children | Phase 2 | Status: TERMINATED